Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • From JHM
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • From JHM
  • Industry Content
    • Patient Monitoring with Tech

Partial Oral Antibiotic Therapy May be Effective in Treating Complicated MRSA Among People with IDU

Clinical question: Are oral antibiotics effective in completing treatment for complicated methicillin-resistant Staphylococcus aureus (MRSA) among patients with injection drug use (IDU)?

Dr. Bredenberg

Dr. Bredenberg

Background: Mounting evidence suggests that oral antibiotics may be effective in completing treatment for invasive infections after an initial period of intravenous (IV) antibiotic therapy. However, prior studies have not focused specifically on people with IDU and/or complicated MRSA bacteremia.

Study design: Retrospective cohort study

Setting: Single-site study at a large teaching hospital in a major metropolitan U.S. area

Synopsis: 238 patients with recent or active IDU during the five-year study period met the inclusion criteria of hospitalization for MRSA bacteremia with complications (endocarditis, septic arthritis, osteomyelitis, or epidural abscess). Patients were divided into the following three groups for comparison: 1. Standard of care—122 patients received a full four to six weeks of inpatient IV antibiotics; 2. Incomplete IV—36 patients received a partial course of IV antibiotics and were discharged without any further antimicrobial treatment; 3. Partial oral—69 patients received a partial course of IV antibiotics and were discharged with oral antibiotics to complete the course. Many patients in this group received intensive outpatient support.

Among patients who received at least 10 days of inpatient IV antibiotics, there was no difference in the primary outcome of treatment failure at 90 days between the group treated with standard-of-care therapy compared to the partial oral therapy group. Patients who received partial IV treatment only without oral therapy had a higher rate of treatment failure as compared to either of the other groups.

Bottom line: Patients with IDU and complicated MRSA infections who leave the hospital before completion of standard-of-care IV antimicrobial therapy should receive oral antibiotics at discharge.

Citation: Wildenthal JA, Atkinson A, et al. Outcomes of partial oral antibiotic treatment for complicated Staphylococcus aureus bacteremia in people who inject drugs. Clin Infect Dis. 2023;76(3):487-96. 

Dr. Bredenberg is an assistant professor in the division of hospital medicine at the University of Colorado Anshutz Medical Campus in Aurora, Colo.

  • Partial Oral Antibiotic Therapy May be Effective in Treating Complicated MRSA Among People with IDU

    December 1, 2023

  • Cellulitis is Frequently Misdiagnosed

    December 1, 2023

  • PE Presents in 1/3 of Patients with Recent Onset of Exertional Dyspnea

    December 1, 2023

  • Anticoagulation for AFib Increases Bleeding Risk and Death in Patients Over 65 with Cognitive Impairment

    December 1, 2023

  • Administering Glucocorticoids Lowers Risk of Death in ICU Patients with Severe CAP

    December 1, 2023

  • Gaps Remain in Hospital Discharge Education

    December 1, 2023

  • Systemic Corticosteroids for Patients with Severe CAP

    December 1, 2023

  • Transcatheter Arterialization Provides Safe and Effective Treatment for No-option CLI

    December 1, 2023

  • How Do We Close the Gap in Gender Disparities Among Hospitalists?

    December 1, 2023

  • SHM SIG Leaders Reflect on 2023

    December 1, 2023

1 … 46 47 48 49 50 … 975
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences